Ficha del valor · trimestre archivado
AKRO
Akero Therapeutics, Inc. · Healthcare · Biotechnology
12Tenedores rastreados
+3Δ titulares
18.33MAcciones mantenidas
$510.05MValor declarado
+3Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +30.0% ·
flujo de acciones +5.7% ·
nuevas posiciones netas +20.0%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2025 | 18 | 0 | 30.14M | $1.43B | +1 | −1 |
| Q2 2025 | 15 | -1 | 29.65M | $1.58B | — | −1 |
| Q1 2025 | 13 | +1 | 19.73M | $798.59M | +1 | — |
| Q4 2024 | 12 | +3 | 18.33M | $510.05M | +3 | — |
| Q3 2024 | 8 | 0 | 15.01M | $430.62M | +1 | −1 |
| Q2 2024 | 8 | — | 11.90M | $279.29M | — | — |
Quién lo tiene en cartera · Q4 2024
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 7.38M | -6.6% | $205.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 4.32M | +13.5% | $120.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 4.32M | +13.5% | $120.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (pasivo) | 2.34M | — | $64.99M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasivo) | 1.56M | -0.7% | $43.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasivo) | 1.56M | -0.7% | $43.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.35M | +803.9% | $37.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.35M | +803.9% | $37.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 899.68K | -31.0% | $25.03M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 275.07K | Nuevo | $7.65M | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 275.07K | Nuevo | $7.65M | 0.0% | New | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 127.32K | +43.4% | $3.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 35.81K | -69.2% | $996,206 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 20.80K | Nuevo | $578,656 | 0.0% | New | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 16.74K | -77.6% | $465,596 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 8.65K | Nuevo | $240,698 | 0.0% | New | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 8.65K | Nuevo | $240,698 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $7.65M | 0.0% |
| Marshall Wace | $7.65M | 0.0% |
| Renaissance Technologies | $578,656 | 0.0% |
| AQR Capital Management | $240,698 | 0.0% |
| AQR Capital Management | $240,698 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q4 2024 ·
Metodología ·
Obtener esto a través de la API